What Happened?
, -based Catalyst Pharmaceuticals Appointed Michael Kalb as CFO
About the Company
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), infantile spasms, and Tourette`s Disorder.
About the Person
Michael Kalb is CFO at Catalyst Pharmaceuticals. Previously, Michael held various senior HR leadership roles in the industry.
Info Source
News
Short Profile